Burak Ezer | Immunology and Microbiology | Best Researcher Award

Dr. Burak Ezer | Immunology and Microbiology | Best Researcher Award

Medical Doctor | Beyhekim Training and Research Hospital | Turkey

Dr. Burak Ezer is a dedicated medical microbiologist whose work spans clinical microbiology, infectious diseases, and rare pathogen case studies. He has made significant contributions to the understanding of fungal and bacterial infections, chronic hepatitis, and viral seroprevalence, publishing extensively in both national and international peer-reviewed journals. His research emphasizes the clinical and diagnostic aspects of emerging pathogens, antimicrobial resistance, and serological markers, often employing advanced molecular and automated techniques. Dr. Ezer has demonstrated strong academic leadership through his role as corresponding author on numerous publications, participation in international and national conferences, and editorial and peer-review responsibilities for indexed journals. He has also contributed to book chapters, further consolidating his expertise in hepatitis and herpesvirus research. His collaborative efforts with multiple co-authors reflect a broad network and commitment to advancing medical science. Dr. Ezer’s measurable research impact is documented through Scopus, showing 9 publications, 1 citation, and an h-index of 1.

Profiles: Scopus | ORCID

Featured Publications

1. Ezer, B., Taşkın, Z., Kaba, K., Uğraklı, S., & Doğan, M. (2025). Comparison of automated systems using liquid microdilution for the determination of colistin resistance in Klebsiella pneumoniae strains. Turkish Bulletin of Hygiene and Experimental Biology.

2. Ezer, B., Esen, H. S., Ugrakli, S., Iyisoy, M. S., & Ozdemir, M. (2025, October 8). Association between serum HBV DNA levels and CCL-20, CD8a, CXCL-16, and GDF-15 in patients with chronic hepatitis B. Viruses.

3. Ezer, B., Ceylan, A., Arazi-Kan, S. N., Uğraklı, S., Bulut, R., & Demircioğlu, S. (2025, September 29). Fungemia caused by Fusarium proliferatum species complex in a patient with acute myeloid leukemia: A rare case report. Klimik Journal.

4. Ezer, B., Uğraklı, S., & Kasapoğlu, E. (2025, September 25). Kandidemi vakalarında hematolojik parametrelerin Albicans ve non-Albicans Candida türleri ile ilişkisi. Flora: The Journal of Infectious Diseases and Clinical Microbiology.

5. Ezer, B., Çiftci, H. S., Uğraklı, S., Bulut, R., & Gök, F. (2025, August 29). Candida auris fungemia confirmed by Sanger sequencing method: A rare case report. Genel Tıp Dergisi.

Kholoud Almahzoum | Microbiology | Most Cited Article Award

Dr. Kholoud Almahzoum | Microbiology | Most Cited Article Award

General practitioners, Jaber hospital, Kuwait

Dr. Kholoud Almahzoum is a dynamic healthcare professional with a rich background in medical education, health information management, and quality improvement. Graduating with a Doctor of Medicine (MD) degree from the University of Jordan in 2024, she has over a decade of expertise in medical record management and healthcare administration. Dr. Almahzoum is the visionary founder of Kuwait Academy, a platform dedicated to fostering medical education and guiding future healthcare professionals. Recognized for her leadership in medical administration, she has been instrumental in enhancing patient outcomes and operational efficiency through collaborative and innovative approaches.

Profile 

Orcid

Education

  • Doctor of Medicine (MD) – University of Jordan (2024): A comprehensive medical education emphasizing clinical excellence and research.
  • Extensive training in health information systems, medical record management, and ICD-10 classification.
  • Certified in quality assurance and healthcare compliance standards, including Canadian accreditation protocols.
  • Specialized in implementing evidence-based practices to optimize patient care and healthcare outcomes.

Experience

  • Deputy of Head of Medical Records, Alsabah Hospital (2009-2011): Promoted evidence-based healthcare.
  • Team Leader, ICD-10 Classification, Ministry of Health (2011-2016): Led a statistical team ranking top diseases.
  • Head of Medical Department, Ibn Sina Hospital (2016-2018): Enhanced departmental efficiency and patient outcomes.
  • Team Leader, Quality Assurance, Ibn Sina Hospital (2016-2018): Achieved Canadian accreditation compliance.
  • Part-Time Teacher/Assistant, PAAET College (2016-2018): Delivered educational sessions in medical records.
  • Head, Kuwait Society University of Jordan Association (2020-2022): Organized events and supported student integration.

Research Focus

Dr. Almahzoum’s research explores intersections of technology, education, and healthcare, with a focus on:

  • Artificial Intelligence in Healthcare: Evaluating AI tools like ChatGPT in clinical and educational applications.
  • Cybersecurity Risks in Healthcare: Addressing vulnerabilities in health information systems.
  • Healthcare Education: Investigating student attitudes and usage of emerging technologies in medical learning.
  • Global Disease Trends: Statistical analysis using ICD-10 classification to understand community health patterns.

Publications

  • 🛡️ Generative Artificial Intelligence and Cybersecurity Risks: Implications for Healthcare Security Based on Real-Life Incidents
  • 🧬 The Performance of OpenAI ChatGPT-4 and Google Gemini in Virology Multiple-Choice Questions: A Comparative Analysis of English and Arabic Responses
  • 📚 Assessing Health Students’ Attitudes and Usage of ChatGPT in Jordan: Validation Study
  • 📝 Assessing Health Students’ Attitudes and Usage of ChatGPT in Jordan: Validation Study (Preprint)

Christy Echakachi Manyi-Loh | Microbiology | Women Researcher Award

Dr. Christy Echakachi Manyi-Loh | Microbiology | Women Researcher Award

Part time lecturer/postdoctoral research fellow, Faculty of Health and Environmental Sciences, Department of Life Sciences, Central University of Technology, Bloemfontein, Free State, South Africa

Christy Echakachi Manyi-Loh is a dedicated researcher and educator in the field of microbiology, currently serving as a part-time lecturer in the Department of Life Sciences at the Central University of Technology in Bloemfontein, South Africa. Born on August 6, 1982, in Cameroon, she has built a remarkable career centered on antimicrobial resistance and renewable energy, showcasing her commitment to addressing public health concerns through her research initiatives.

Profile

Scopus

Education 🎓

Christy’s academic journey began at the University of Buea in Cameroon, where she earned her Bachelor of Science in Microbiology (2000-2003) and a Master of Science in Microbiology (2004-2007), graduating with a GPA of 3.14/4. She then pursued her Doctorate at the University of Fort Hare in South Africa, completing her Ph.D. in Microbiology from 2009 to 2012. Her extensive education laid the foundation for her expertise in microbiology, particularly in the areas of environmental and applied microbiology.

Experience 💼

With over two decades of experience in academia and research, Christy has held various positions. She has worked as a tutor and demonstrator at the University of Fort Hare, where she honed her teaching skills from 2010 to 2012. Currently, she balances her role as a part-time lecturer at the Central University of Technology with postdoctoral fellowships focusing on food safety culture and renewable energy. Her managerial experience includes overseeing a daycare center and serving as the General Manager of S and L TECH (Pty), where she is involved in editing and proofreading.

Research Interests 🔬

Christy’s research interests encompass antimicrobial resistance, natural products, renewable energy, and the microbial dynamics involved in biogas production. She has managed multiple interdisciplinary research projects, focusing on the health implications of microbial contamination in food and the efficacy of biogas technology in energy generation and waste management. Her work is characterized by a strong emphasis on sustainability and public health.

Awards 🏆

Throughout her career, Christy has received several prestigious awards, including the Dean’s Trophy for the Best Publication in 2023 and multiple postdoctoral fellowships from renowned organizations such as the Whole and Retail Sector Education Training Authority and the National Research Foundation of South Africa. She was also recognized as the Best Student in Research Project by The American Society of Microbiology in 2007 and received the Senate Prize for Best Student in Microbiology during her undergraduate studies.

Publications  Top Notes📚

Christy has made significant contributions to the field of microbiology, authoring numerous research articles in peer-reviewed journals. Below is a selection of her notable publications:

  1. Manyi-Loh, C.E., Lues, R. (2023). A South African Perspective on the Microbiological and Chemical Quality of Meat: Plausible Public Health Implications. Microorganisms, 11, 2484. Link
    Cited by: Cite This Article
  2. Manyi-Loh, C.E.; Lues, R. (2023). Anaerobic Digestion of Lignocellulosic Biomass: Substrate Characteristics (Challenge) and Innovation. Fermentation, 9, 755. Link
    Cited by: Cite This Article
  3. Manyi-Loh, C.E.; Okoh, A.I.; Lues, R. (2023). Occurrence and Multidrug Resistance in Strains of Listeria monocytogenes Recovered from the Anaerobic Co-Digestion Sludge Contained in a Single Stage Steel Biodigester: Implications for Antimicrobial Stewardship. Microorganisms, 11, 725. Link
    Cited by: Cite This Article
  4. Manyi-Loh, C.E., Okoh, A.I., Lues, R. (2023). Prevalence of Multidrug-Resistant Bacteria (Enteropathogens) Recovered from a Blend of Pig Manure and Pinewood Saw Dust during Anaerobic Co-Digestion in a Steel Biodigester. International Journal of Environmental Research and Public Health, 20, 984. Link
    Cited by: Cite This Article
  5. Manyi-Loh, C.E., Lues, R. (2022). Reduction in Bacterial Pathogens in a Single Stage Steel Biodigester Co-Digesting Saw Dust and Pig Manure at Psychrophilic Temperature. Applied Sciences, 12. Link
    Cited by: Cite This Article

TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Prof. TOSHIFUMI OHKUSA | Microbiology | Best Researcher Award

Special Professor, juntendo, Japan

Dr. Toshifumi Ohkusa is a highly regarded expert in gastroenterology and microbiota research, with a distinguished career spanning over four decades. He is currently a Special Professor at the Department of Microbiota Research at Juntendo University Graduate School of Medicine. Dr. Ohkusa has made significant contributions to the field of gastroenterology, particularly in understanding ulcerative colitis and intestinal microflora. 🌟👨‍⚕️

Publication profile

Scopus

 

Education

Dr. Ohkusa completed his medical degree (M.D.) from Tokyo Medical and Dental University in 1978. He pursued a Ph.D. from the same institution, where his groundbreaking research on ulcerative colitis in hamsters through dextran sulfate sodium and changes in intestinal microflora earned him a doctorate in 1986. 🎓📚

Experience

With an impressive academic journey, Dr. Ohkusa served as a Research Associate and Instructor at Tokyo Medical and Dental University from 1986 to 2001. He later joined Juntendo University, where he advanced from Assistant Professor to Associate Professor in the Department of Gastroenterology. Between 2008 and 2017, he held the prestigious position of Professor at The Jikei University Kashiwa Hospital. Currently, he leads microbiota research at Juntendo University. 💼🔬

Research Focus

Dr. Ohkusa’s research focuses on gastroenterology, particularly the mechanisms of ulcerative colitis and the role of intestinal microflora in gastrointestinal diseases. His work on microbiota research has significantly advanced the understanding of gastrointestinal health. 🔬🧫

Awards and Honors

Dr. Ohkusa has received numerous accolades for his groundbreaking work in gastroenterology and internal medicine, earning recognition from both Japanese and international medical societies. 🏆🌍

Publication Top Notes

Effect of probiotic bifidobacterium breve in improving cognitive function and preventing brain atrophy in older patients with suspected mild cognitive impairment: Results of a 24-week randomized, double-blind, placebo-controlled trial

Analysis of the NUDT15 gene and metabolites of azathioprine in Japanese patients with inflammatory bowel disease

Correction: The insoluble excretion of multi-matrix system mesalazine preparations in patients with ulcerative colitis (BMC Gastroenterology, (2022), 22, 1, (390), 10.1186/s12876-022-02474-9)